Filing Details
- Accession Number:
- 0001181431-11-061936
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-12-23 18:22:44
- Reporting Period:
- 2011-12-21
- Filing Date:
- 2011-12-23
- Accepted Time:
- 2011-12-23 18:22:44
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1316175 | Anthera Pharmaceuticals Inc | ANTH | Pharmaceutical Preparations (2834) | 201852016 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1245624 | James Healy | C/O Sofinnova Ventures 2800 Sand Hill Road, Suite 150 Menlo Park CA 94025 | Yes | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2011-12-21 | 20,630 | $6.51 | 3,339,944 | No | 4 | S | Indirect | See footnote. |
Common Stock | Disposition | 2011-12-21 | 4,090 | $6.51 | 661,730 | No | 4 | S | Indirect | See footnote. |
Common Stock | Disposition | 2011-12-21 | 280 | $6.51 | 45,529 | No | 4 | S | Indirect | See footnote. |
Common Stock | Disposition | 2011-12-22 | 20,630 | $6.22 | 3,319,314 | No | 4 | S | Indirect | See footnote. |
Common Stock | Disposition | 2011-12-22 | 4,090 | $6.22 | 657,640 | No | 4 | S | Indirect | See footnote. |
Common Stock | Disposition | 2011-12-22 | 280 | $6.22 | 45,249 | No | 4 | S | Indirect | See footnote. |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | See footnote. |
No | 4 | S | Indirect | See footnote. |
No | 4 | S | Indirect | See footnote. |
No | 4 | S | Indirect | See footnote. |
No | 4 | S | Indirect | See footnote. |
No | 4 | S | Indirect | See footnote. |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 20,443 | Direct |
Footnotes
- Shares are held by Sofinnova Venture Partners VI, L.P. ("SV VI"). Sofinnova Management VI, L.L.C. ("SV LLC") is the general partner of SV VI and James I. Healy ("Healy"), a director of the issuer, Michael F. Powell ("Powell"), Alain L. Azan ("Azan") and Eric P. Buatois ("Buatois"), the managing members of SV LLC, may be deemed to share voting and dispositive power over the shares held by such entities.
- Shares are held by Sofinnova Venture Partners VI GmbH & Co. KG ("SV KG"). SV LLC is the general partner of SV KG, and Healy, Powell, Azan and Buatois, the managing members of SV LLC, may be deemed to share voting and dispositive power over the shares held by such entities.
- Shares are held by Sofinnova Venture Affiliates VI L.P. ("SV A"). SV LLC is the general partner of SV A, and Healy, Powell, Azan and Buatois, the managing members of SV LLC, may be deemed to share voting and dispositive power over the shares held by such entities.